We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $25B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+9.58%
1 Year Est. Return
+18.87%
3 Year Est. Return
+73.23%
5 Year Est. Return
+90.52%
10 Year Est. Return
+458.69%
AUM
$2.94B
AUM Growth
+$304M
Cap. Flow
+$71.7M
Cap. Flow %
2.44%
Top 10 Hldgs %
30.8%
Holding
315
New
11
Increased
100
Reduced
87
Closed
13

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$26.2M
2
PFE icon
Pfizer
PFE
+$6.86M
3
HD icon
Home Depot
HD
+$6.66M
4
FRC
First Republic Bank
FRC
+$6.59M
5
V icon
Visa
V
+$5.61M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$18.4M
2
KDP icon
Keurig Dr Pepper
KDP
+$10.8M
3
PPG icon
PPG Industries
PPG
+$6.71M
4
VZ icon
Verizon
VZ
+$4.77M
5
AMZN icon
Amazon
AMZN
+$4.75M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 18.39%
3 Healthcare 13.94%
4 Consumer Discretionary 10.71%
5 Communication Services 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
51
Citigroup
C
$217B
$17.2M 0.58%
239,505
+12,301
+5% +$870K
BNS icon
52
Scotiabank
BNS
$107B
$15.8M 0.54%
265,178
-788
-0.3% -$46K
HON icon
53
Honeywell
HON
$71.7B
$15.4M 0.52%
102,626
+15,798
+18% +$2.24M
EL icon
54
Estee Lauder
EL
$30B
$14.8M 0.5%
101,989
+17,435
+21% +$2.42M
PG icon
55
Procter & Gamble
PG
$347B
$14.1M 0.48%
169,180
+50,250
+42% +$4.11M
SLB icon
56
SLB Ltd
SLB
$69.9B
$14M 0.48%
230,411
+14,803
+7% +$953K
AMGN icon
57
Amgen
AMGN
$197B
$13.8M 0.47%
66,661
-362
-0.5% -$71.3K
CVX icon
58
Chevron
CVX
$378B
$13.5M 0.46%
110,636
+26,788
+32% +$3.25M
ULTA icon
59
Ulta Beauty
ULTA
$20.9B
$13.4M 0.46%
47,589
+952
+2% +$243K
NTRS icon
60
Northern Trust
NTRS
$33.9B
$13.1M 0.45%
128,467
+12,667
+11% +$1.36M
GLD icon
61
SPDR Gold Trust
GLD
$129B
$12.5M 0.42%
110,630
+4,976
+5% +$571K
ABT icon
62
Abbott
ABT
$178B
$12.2M 0.42%
166,653
-17,004
-9% -$1.12M
MDLZ icon
63
Mondelez International
MDLZ
$77.4B
$11.3M 0.38%
262,683
-7,597
-3% -$324K
MRSH
64
Marsh
MRSH
$87.5B
$10.3M 0.35%
124,883
-575
-0.5% -$48.7K
RTN
65
DELISTED
Raytheon Company
RTN
$9.99M 0.34%
48,353
+373
+0.8% +$74.3K
GE icon
66
GE Aerospace
GE
$354B
$8.93M 0.3%
164,969
-15,889
-9% -$979K
AJG icon
67
Arthur J. Gallagher & Co
AJG
$65.2B
$8.89M 0.3%
119,450
-215
-0.2% -$15.4K
NFLX icon
68
Netflix
NFLX
$283B
$8.37M 0.28%
223,730
+27,250
+14% +$989K
ABBV icon
69
AbbVie
ABBV
$448B
$8.28M 0.28%
87,575
-300
-0.3% -$28.4K
USB icon
70
US Bancorp
USB
$98.5B
$8.09M 0.27%
153,241
+21,500
+16% +$1.14M
LLY icon
71
Eli Lilly
LLY
$1.03T
$8.08M 0.27%
75,259
-335
-0.4% -$33.5K
CM icon
72
Canadian Imperial Bank of Commerce
CM
$108B
$7.83M 0.27%
167,370
KHC icon
73
Kraft Heinz
KHC
$30.9B
$7.83M 0.27%
142,065
-13,421
-9% -$802K
PEP icon
74
PepsiCo
PEP
$184B
$7.68M 0.26%
68,701
-3,310
-5% -$375K
XYL icon
75
Xylem
XYL
$28.7B
$7.67M 0.26%
96,091
+741
+0.8% +$55.3K

Similar funds

Rathbones Group's Q3 2018 Portfolio in Review

As of Q3 2018, Rathbones Group held 315 positions worth $2.94B, up 12% from $2.64B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rathbones Group's Q3 2018 filing shows 11 new, 100 increased, 87 reduced and 13 closed positions. Its largest new stake was Idexx Laboratories: 107,900 shares worth $26.9M. The largest sale was Lockheed Martin, an estimated $18.4M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Rathbones Group's largest Q3 2018 buy was Idexx Laboratories: 107,900 shares worth $26.9M.
  • Rathbones Group added most to Pfizer in Q3 2018, an estimated $6.86M increase.
  • Rathbones Group's biggest Q3 2018 reduction was Lockheed Martin, cutting an estimated $18.4M.
  • Rathbones Group fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $10.8M.
  • Rathbones Group's ten largest holdings make up 31% of its $2.94B portfolio in Q3 2018.
  • Rathbones Group opened 11 new positions and closed 13 in Q3 2018.
  • Rathbones Group's portfolio value rose 12% quarter-over-quarter to $2.94B.

Based on Rathbones Group's 13F filing for Q3 2018, filed 12 Oct 2018.